Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity - United States, 2005-2014

C Brooke Steele, Cheryll C Thomas, S Jane Henley, Greta M Massetti, Deborah A Galuska, Tanya Agurs-Collins, Mary Puckett, Lisa C Richardson, C Brooke Steele, Cheryll C Thomas, S Jane Henley, Greta M Massetti, Deborah A Galuska, Tanya Agurs-Collins, Mary Puckett, Lisa C Richardson

Abstract

Background: Overweight and obesity are associated with increased risk of at least 13 different types of cancer.

Methods: Data from the United States Cancer Statistics for 2014 were used to assess incidence rates, and data from 2005 to 2014 were used to assess trends for cancers associated with overweight and obesity (adenocarcinoma of the esophagus; cancers of the breast [in postmenopausal women], colon and rectum, endometrium, gallbladder, gastric cardia, kidney, liver, ovary, pancreas, and thyroid; meningioma; and multiple myeloma) by sex, age, race/ethnicity, state, geographic region, and cancer site. Because screening for colorectal cancer can reduce colorectal cancer incidence through detection of precancerous polyps before they become cancerous, trends with and without colorectal cancer were analyzed.

Results: In 2014, approximately 631,000 persons in the United States received a diagnosis of a cancer associated with overweight and obesity, representing 40% of all cancers diagnosed. Overweight- and obesity-related cancer incidence rates were higher among older persons (ages ≥50 years) than younger persons; higher among females than males; and higher among non-Hispanic black and non-Hispanic white adults compared with other groups. Incidence rates for overweight- and obesity-related cancers during 2005-2014 varied by age, cancer site, and state. Excluding colorectal cancer, incidence rates increased significantly among persons aged 20-74 years; decreased among those aged ≥75 years; increased in 32 states; and were stable in 16 states and the District of Columbia.

Conclusions: The burden of overweight- and obesity-related cancer is high in the United States. Incidence rates of overweight- and obesity-related cancers except colorectal cancer have increased in some age groups and states.

Implications for public health practice: The burden of overweight- and obesity-related cancers might be reduced through efforts to prevent and control overweight and obesity. Comprehensive cancer control strategies, including use of evidence-based interventions to promote healthy weight, could help decrease the incidence of these cancers in the United States.

Conflict of interest statement

Conflict of Interest: No conflicts of interest were reported.

Figures

FIGURE 1
FIGURE 1
Average annual percent change in overweight- and obesity-related invasive cancer incidence rates among adults — United States, 2005–2014 * Average annual percent change (AAPC) was calculated using joinpoint regression, which allowed different slopes for two periods; the year at which slopes changed could vary by age. All AAPCs were significantly different from zero (p† Overweight- and obesity-related cancer (adenocarcinoma of the esophagus; cancers of the breast [in postmenopausal women], colon and rectum, endometrium, gallbladder, gastric cardia, kidney, liver, ovary, pancreas, and thyroid; meningioma; and multiple myeloma) rates were calculated with and without colorectal cancer because colorectal cancer screening can detect precancerous polyps before they become cancerous, which might affect cancer incidence. § Cancer incidence compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for each year during the period 2005–2014 (covering 99% of the U.S. population).
FIGURE 2
FIGURE 2
Average annual percent change in incidence of overweight- and obesity-related cancers, by quartile — United States, 2005–2014 * Except colorectal cancer.

References

    1. National Center for Health Statistics. Prevalence of overweight, obesity, and extreme obesity among adults aged 20 and over: United States, 1960–1962 through 2013–2014. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2016.
    1. American Institute for Cancer Research. The AICR 2015. cancer risk survey report. Washington, DC: American Institute for Cancer Research; 2015.
    1. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer—viewpoint of the IARC Working Group. N Engl J Med 2016;375:794–8. 10.1056/NEJMsr1606602
    1. Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 2015;15:484–98. 10.1038/nrc3967
    1. White A, Thompson TD, White MC, et al. Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 2017;66:201–6. 10.15585/mmwr.mm6608a1
    1. Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012;41:1706–18. 10.1093/ije/dys176
    1. Chen Y, Liu L, Wang X, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev 2013;22:1395–408. 10.1158/1055-9965.EPI-13-0042
    1. Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer 2012;48:2137–45. 10.1016/j.ejca.2012.02.063
    1. Wang F, Xu Y. Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer 2014;135:1673–86. 10.1002/ijc.28813
    1. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013;8:e53916. 10.1371/journal.pone.0053916
    1. Setiawan VW, Yang HP, Pike MC, et al.; Australian National Endometrial Cancer Study Group. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013;31:2607–18. 10.1200/JCO.2012.48.2596
    1. Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015;107:djv088. 10.1093/jnci/djv088
    1. Luo J, Chlebowski RT, Hendryx M, et al. Intentional weight loss and endometrial cancer risk. J Clin Oncol 2017;35:1189–93. 10.1200/JCO.2016.70.5822
    1. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006;296:193–201. 10.1001/jama.296.2.193
    1. Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012;118:2338–66. 10.1002/cncr.27514
    1. Institute of Medicine. Accelerating progress in obesity prevention: solving the weight of the nation. Washington, DC: National Academies Press; 2012.
    1. Puckett M, Neri A, Underwood JM, Stewart SL. Nutrition and physical activity strategies for cancer prevention in current National Comprehensive Cancer Control Program plans. J Community Health 2016;41:1013–20. 10.1007/s10900-016-0184-8

Source: PubMed

3
Abonneren